The Michael J. Fox Foundation Annual Report 2016 – Frameworks for Progress | Page 15

Industry Partners
The Michael J. Fox Foundation is grateful
to the biotechnology and pharmaceutical
companies whose support helps us accelerate
clinical trial engagement, bring together the
nationwide Parkinson’s community and push
PD research forward. Collectively, these
partners contributed more than $6 million to
our programs in 2016.
We also extend our thanks to the 2016 Parkinson’s Disease Education
Consortium, an alliance of industry partners who support our
commitment to furnishing high-quality educational resources for the
Parkinson’s community while preserving our track record of efficiency
in stewarding donor-raised contributions for maximum impact on
Parkinson’s drug development.
Learn more at michaeljfox.org/sponsors.
AbbVie GlaxoSmithKline
Acadia Pharmaceuticals Institut de Recherche Servier
Acorda Therapeutics Lundbeck
Adamas Pharmaceuticals Medtronic
Amicus Therapeutics Merck Sharp & Dohme Corp.
AstraZeneca Meso Scale Diagnostics
Atuka Avid Radiopharmaceuticals Pfizer Global Research
and Development
Biogen Sanofi Genzyme
Biotechnology Industry
Organization Senior Helpers
Bristol Meyers Squibb Teva Pharmaceutical Industries
Charles River Laboratories UCB
Sunovion Pharmaceuticals
GE Healthcare
2016 Annual Report
13